Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Protease- and cell type-specific activation of protease-activated receptor 2 in cutaneous inflammation.
J Thromb Haemost. 2022 Dec;20(12):2823-2836. doi: 10.1111/jth.15894. Epub 2022 Oct 12.
J Thromb Haemost. 2022.
PMID: 36161697
Free article.
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.
Haist M, Stege H, Ebner R, Fleischer MI, Loquai C, Grabbe S.
Haist M, et al. Among authors: fleischer mi.
Cancers (Basel). 2022 Apr 21;14(9):2082. doi: 10.3390/cancers14092082.
Cancers (Basel). 2022.
PMID: 35565212
Free PMC article.
Item in Clipboard
Retrospective Analysis of Checkpoint Inhibitor Therapy-Associated Cases of Bullous Pemphigoid From Six German Dermatology Centers.
Sadik CD, Langan EA, Gutzmer R, Fleischer MI, Loquai C, Reinhardt L, Meier F, Göppner D, Herbst RA, Zillikens D, Terheyden P.
Sadik CD, et al. Among authors: fleischer mi.
Front Immunol. 2021 Feb 23;11:588582. doi: 10.3389/fimmu.2020.588582. eCollection 2020.
Front Immunol. 2021.
PMID: 33708189
Free PMC article.
Item in Clipboard
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Stege H, Haist M, Schultheis M, Fleischer MI, Mohr P, Meier F, Schadendorf D, Ugurel S, Livingstone E, Zimmer L, Herbst R, Pföhler C, Kähler K, Weichenthal M, Terheyden P, Nashan D, Debus D, Kaatz M, Ziller F, Haferkamp S, Forschner A, Leiter U, Kreuter A, Ulrich J, Kleemann J, Bradfisch F, Grabbe S, Loquai C.
Stege H, et al. Among authors: fleischer mi.
Cancers (Basel). 2021 May 12;13(10):2312. doi: 10.3390/cancers13102312.
Cancers (Basel). 2021.
PMID: 34065877
Free PMC article.
Item in Clipboard
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.
Haist M, Stege H, Pemler S, Heinz J, Fleischer MI, Graf C, Ruf W, Loquai C, Grabbe S.
Haist M, et al. Among authors: fleischer mi.
Cancers (Basel). 2021 Oct 12;13(20):5103. doi: 10.3390/cancers13205103.
Cancers (Basel). 2021.
PMID: 34680252
Free PMC article.
Item in Clipboard
Cite
Cite